Tallahassee, Fla. — This evening, without any advanced notice, the U.S. Food and Drug Administration (FDA) revised the Emergency Use Authorizations (EUA) for bamlanivimab/etesevimab and REGEN-COV. The revised EUAs do not allow providers to administer these treatments within the United States.
- Florida Department of Health Welcomes New State Emergency Medical Services Medical Director
- Florida to Open Additional Monoclonal Antibody Therapy Treatment Sites
- Florida Department of Health Issues New COVID-19 Testing Guidance
- State Surgeon General Calls on Federal Government to Stop Actively Preventing Distribution of COVID-19 Therapeutics
- Health Officials Issue Blue-Green Algae Bloom Alert
- DEPARTMENT OF HEALTH RECOGNIZES WORLD AIDS DAY - DECEMBER 1
- Health Officials Lift Blue-Green Algae Bloom Alert for Martin County
- Keep Food Safety a Priority for a Healthy Holiday Season
- Martin County Bacteria Levels Elevated - Residents urged to avoid contact with waters near the Roosevelt Bridge and Leighton Park in Palm City.
Upcoming EventsMore Events...
772-221-4000 Option 6
|Download the Full List of Reportable Diseases and Conditions|
Popular Programs & Services
Medical Quality Assurance Services
For Health care Professionals